[Skip to Navigation]
Sign In
Editorial
September 29, 2021

Vasopressin and Steroids as Adjunctive Treatment for In-Hospital Cardiac Arrest

Author Affiliations
  • 1Department of Emergency Medicine, Denver Health and the University of Colorado School of Medicine, Denver
  • 2Department of Epidemiology, Colorado School of Public Health, Aurora
  • 3Division of Pulmonary Sciences and Critical Care Medicine, Denver Health and the University of Colorado School of Medicine, Denver
  • 4American Heart Association, Dallas, Texas
JAMA. 2021;326(16):1583-1585. doi:10.1001/jama.2021.15460

Cardiopulmonary arrest occurs in approximately 290 000 hospitalized patients annually in the United States, representing nearly 1% of all admissions and with survival estimated at 20%.1 To date, most research on cardiopulmonary arrest has focused on patients who experience cardiac arrest in the out-of-hospital setting with results extrapolated to those with cardiac arrest in hospitals. However, there are distinct differences in the treatment of patients who experience cardiac arrest in the hospital setting where disease processes, etiologies, and illness severity differ and medical response time is often shorter.

Add or change institution
×